CASR and Alzheimer disease: Given the potential value for AD therapy, in this work, we explored for the first time the mechanisms underlying the beneficial effects of NPS 2143 in human astrocytes, particularly the effects of Aβ•CaSR signalling on the NAP of hAPP and the modulation of such effects by a calcilytic.